Cargando…

Effect of bolus enteral tube feeding on body weight in ambulatory adults with obesity and type 2 diabetes: a feasibility pilot randomized trial

BACKGROUND/OBJECTIVES: To ascertain the effect on body weight of 14 days of bolus enteral feeding with mixed meal (MM) and electrolyte solution (ES) in ambulatory adults with type 2 diabetes and obesity, and also the safety and feasibility of using a modified, intraorally anchored enteral feeding tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Beale, E. O., Lee, W., Lee, A., Lee, C., Soffer, E., Crookes, P. F., Eagilen, K., Chen, R., Mack, W. J., Tong, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298641/
https://www.ncbi.nlm.nih.gov/pubmed/32555148
http://dx.doi.org/10.1038/s41387-020-0125-6
_version_ 1783547242309746688
author Beale, E. O.
Lee, W.
Lee, A.
Lee, C.
Soffer, E.
Crookes, P. F.
Eagilen, K.
Chen, R.
Mack, W. J.
Tong, H.
author_facet Beale, E. O.
Lee, W.
Lee, A.
Lee, C.
Soffer, E.
Crookes, P. F.
Eagilen, K.
Chen, R.
Mack, W. J.
Tong, H.
author_sort Beale, E. O.
collection PubMed
description BACKGROUND/OBJECTIVES: To ascertain the effect on body weight of 14 days of bolus enteral feeding with mixed meal (MM) and electrolyte solution (ES) in ambulatory adults with type 2 diabetes and obesity, and also the safety and feasibility of using a modified, intraorally anchored enteral feeding tube for this purpose. SUBJECTS/METHODS: We conducted a randomized, crossover pilot trial with 16 participants. A 140 cm, 8-French feeding tube was placed in the jejunum under electromagnetic guidance and anchored intraorally. Participants were randomized to self-administer 120 mL 523 kJ (125 kcal) MM, or 50 kJ (12 kcal) ES four times/day for 14 days. After ≥14 days without the tube, participants crossed over to the other treatment. The primary outcome compared weight change between treatments. Thereafter, participants could elect to undergo additional MM cycles. Participants were encouraged to continue with all usual activities including eating ad lib throughout the study. RESULTS: Ten participants withdrew prior to completing two randomized 14-day cycles (4 social, 3 intolerant of anchor, and 3 intolerant of tube). Six participants were assessed for the primary outcome and showed no significant difference in weight loss between MM and ES (p = 0.082). For the secondary outcome of within-group weight loss, average weight loss from baseline was significant for MM but not for ES: −2.40 kg (95% CI: −3.78, −1.02; p = 0.008) vs. −0.64 kg (95% CI: −2.01, 0.74; p = 0.27). A total of 23 2-week cycles were completed (12 paired, 2 unpaired, and 9 additional), with no significant adverse events for 334 days of tube use. CONCLUSIONS: Repeated bolus nutrient administration via enteral feeding tube is associated with weight loss in adults with obesity and type 2 diabetes, with no significant difference seen between MM and ES feeds. The prototype device was safe, but requires development for further investigation into the effect of bolus jejunal feeding on weight and to improve acceptability.
format Online
Article
Text
id pubmed-7298641
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72986412020-06-22 Effect of bolus enteral tube feeding on body weight in ambulatory adults with obesity and type 2 diabetes: a feasibility pilot randomized trial Beale, E. O. Lee, W. Lee, A. Lee, C. Soffer, E. Crookes, P. F. Eagilen, K. Chen, R. Mack, W. J. Tong, H. Nutr Diabetes Article BACKGROUND/OBJECTIVES: To ascertain the effect on body weight of 14 days of bolus enteral feeding with mixed meal (MM) and electrolyte solution (ES) in ambulatory adults with type 2 diabetes and obesity, and also the safety and feasibility of using a modified, intraorally anchored enteral feeding tube for this purpose. SUBJECTS/METHODS: We conducted a randomized, crossover pilot trial with 16 participants. A 140 cm, 8-French feeding tube was placed in the jejunum under electromagnetic guidance and anchored intraorally. Participants were randomized to self-administer 120 mL 523 kJ (125 kcal) MM, or 50 kJ (12 kcal) ES four times/day for 14 days. After ≥14 days without the tube, participants crossed over to the other treatment. The primary outcome compared weight change between treatments. Thereafter, participants could elect to undergo additional MM cycles. Participants were encouraged to continue with all usual activities including eating ad lib throughout the study. RESULTS: Ten participants withdrew prior to completing two randomized 14-day cycles (4 social, 3 intolerant of anchor, and 3 intolerant of tube). Six participants were assessed for the primary outcome and showed no significant difference in weight loss between MM and ES (p = 0.082). For the secondary outcome of within-group weight loss, average weight loss from baseline was significant for MM but not for ES: −2.40 kg (95% CI: −3.78, −1.02; p = 0.008) vs. −0.64 kg (95% CI: −2.01, 0.74; p = 0.27). A total of 23 2-week cycles were completed (12 paired, 2 unpaired, and 9 additional), with no significant adverse events for 334 days of tube use. CONCLUSIONS: Repeated bolus nutrient administration via enteral feeding tube is associated with weight loss in adults with obesity and type 2 diabetes, with no significant difference seen between MM and ES feeds. The prototype device was safe, but requires development for further investigation into the effect of bolus jejunal feeding on weight and to improve acceptability. Nature Publishing Group UK 2020-06-17 /pmc/articles/PMC7298641/ /pubmed/32555148 http://dx.doi.org/10.1038/s41387-020-0125-6 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Beale, E. O.
Lee, W.
Lee, A.
Lee, C.
Soffer, E.
Crookes, P. F.
Eagilen, K.
Chen, R.
Mack, W. J.
Tong, H.
Effect of bolus enteral tube feeding on body weight in ambulatory adults with obesity and type 2 diabetes: a feasibility pilot randomized trial
title Effect of bolus enteral tube feeding on body weight in ambulatory adults with obesity and type 2 diabetes: a feasibility pilot randomized trial
title_full Effect of bolus enteral tube feeding on body weight in ambulatory adults with obesity and type 2 diabetes: a feasibility pilot randomized trial
title_fullStr Effect of bolus enteral tube feeding on body weight in ambulatory adults with obesity and type 2 diabetes: a feasibility pilot randomized trial
title_full_unstemmed Effect of bolus enteral tube feeding on body weight in ambulatory adults with obesity and type 2 diabetes: a feasibility pilot randomized trial
title_short Effect of bolus enteral tube feeding on body weight in ambulatory adults with obesity and type 2 diabetes: a feasibility pilot randomized trial
title_sort effect of bolus enteral tube feeding on body weight in ambulatory adults with obesity and type 2 diabetes: a feasibility pilot randomized trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298641/
https://www.ncbi.nlm.nih.gov/pubmed/32555148
http://dx.doi.org/10.1038/s41387-020-0125-6
work_keys_str_mv AT bealeeo effectofbolusenteraltubefeedingonbodyweightinambulatoryadultswithobesityandtype2diabetesafeasibilitypilotrandomizedtrial
AT leew effectofbolusenteraltubefeedingonbodyweightinambulatoryadultswithobesityandtype2diabetesafeasibilitypilotrandomizedtrial
AT leea effectofbolusenteraltubefeedingonbodyweightinambulatoryadultswithobesityandtype2diabetesafeasibilitypilotrandomizedtrial
AT leec effectofbolusenteraltubefeedingonbodyweightinambulatoryadultswithobesityandtype2diabetesafeasibilitypilotrandomizedtrial
AT soffere effectofbolusenteraltubefeedingonbodyweightinambulatoryadultswithobesityandtype2diabetesafeasibilitypilotrandomizedtrial
AT crookespf effectofbolusenteraltubefeedingonbodyweightinambulatoryadultswithobesityandtype2diabetesafeasibilitypilotrandomizedtrial
AT eagilenk effectofbolusenteraltubefeedingonbodyweightinambulatoryadultswithobesityandtype2diabetesafeasibilitypilotrandomizedtrial
AT chenr effectofbolusenteraltubefeedingonbodyweightinambulatoryadultswithobesityandtype2diabetesafeasibilitypilotrandomizedtrial
AT mackwj effectofbolusenteraltubefeedingonbodyweightinambulatoryadultswithobesityandtype2diabetesafeasibilitypilotrandomizedtrial
AT tongh effectofbolusenteraltubefeedingonbodyweightinambulatoryadultswithobesityandtype2diabetesafeasibilitypilotrandomizedtrial